Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Rheumatology

Reading Your Reports: Lab Tests and Biopsies in MPA

At a Glance

Microscopic polyangiitis (MPA) is primarily diagnosed through an ANCA panel blood test and a kidney biopsy. Key findings that confirm an MPA diagnosis include a positive MPO-ANCA blood test and biopsy results showing pauci-immune, necrotizing damage to small blood vessels without granulomas.

Reviewing your medical records can feel like learning a foreign language. However, your lab and pathology reports are the “blueprints” your doctors use to build your treatment plan. In Microscopic Polyangiitis (MPA), these reports focus on identifying specific markers in your blood and microscopic damage in your tissues [1][2].

Decoding Your Blood Work (Labs)

The most important part of your lab report is the ANCA panel. This blood test looks for antibodies that shouldn’t be there [3][4].

  • MPO-ANCA: This is the specific marker for MPA. About 80% of people with MPA test positive for this antibody, which targets an enzyme called myeloperoxidase [4].
  • p-ANCA: You might see this term on older reports or screening tests. It describes a “perinuclear” pattern (the way the antibodies look under a microscope). While it is common in MPA, the MPO-ANCA test is more specific and modern [3][5].
  • PR3-ANCA: While this is usually associated with a sister disease (GPA), a small percentage of MPA patients do test positive for PR3-ANCA [6]. If you carry this marker, it indicates a slightly higher risk of relapse, and your doctor will tailor your monitoring accordingly [7][6].

Note on ANCA-Negative Disease: A small percentage of patients with biopsy-proven MPA may actually test negative for both MPO and PR3 ANCA. If you are ANCA-negative, it does not mean your diagnosis is wrong; doctors will simply rely more heavily on your biopsy results [8].

Decoding Your Biopsy Report (Pathology)

A kidney biopsy is considered the “gold standard” for confirming MPA [9]. The pathologist looks for several key features:

  • Pauci-Immune: This is a hallmark of MPA. It means that while there is severe damage to the blood vessels, the pathologist sees “few” (pauci) antibody clumps stuck in the tissue [10].
  • Necrotizing: This term describes tissue death (necrosis) within the walls of your small blood vessels caused by intense inflammation [11].
  • Crescentic Glomerulonephritis: If you see this on your report, it means the inflammation has caused layers of cells to form a “crescent” shape around the kidney’s filters (glomeruli) [8]. This is a sign of active, serious disease that requires prompt treatment to protect kidney function [12].

Diagnostic Completeness Checklist

To ensure your diagnosis is as accurate as possible according to the latest ACR/EULAR guidelines, your medical file should ideally contain the following [13][14]:

Test Category What to Look For Why it Matters
Blood Work MPO-ANCA (antigen-specific) Confirms the type of vasculitis [3]
Biopsy Description of Glomeruli Shows the extent of kidney involvement [1]
Biopsy Statement on Granulomas If absent, it supports MPA over GPA [14]
Imaging Chest CT scan Checks for “silent” lung involvement or scarring [15]
Kidney Function Creatinine and uPCR Tracks how well your kidneys are filtering protein [16]

Common questions in this guide

What does MPO-ANCA positive mean for MPA?
MPO-ANCA is an antibody that targets an enzyme called myeloperoxidase. Testing positive for this marker is a hallmark sign of microscopic polyangiitis and helps doctors confirm your specific type of vasculitis.
Can I have microscopic polyangiitis if my ANCA test is negative?
Yes, a small percentage of patients with MPA test negative for ANCA antibodies. In these cases, doctors rely more heavily on kidney biopsy results and clinical symptoms to confirm the diagnosis.
What does pauci-immune mean on my kidney biopsy report?
Pauci-immune means there are very few antibody clumps visible in the damaged tissue under a microscope. This is a classic feature of microscopic polyangiitis and helps pathologists distinguish it from other kidney diseases.
What is crescentic glomerulonephritis?
This means intense inflammation has caused cells to form a crescent shape around the filtering units of your kidneys. It indicates active, serious disease that requires prompt treatment to protect your kidney function.
Why does my doctor check for granulomas on my biopsy?
Granulomas are specific clusters of inflammatory cells. Their absence in a tissue biopsy helps pathologists confirm microscopic polyangiitis (MPA) rather than a closely related condition called granulomatosis with polyangiitis (GPA).

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Was my diagnosis confirmed using the specific MPO-ANCA immunoassay, or just a general p-ANCA screening?
  2. 2.Does my kidney biopsy report mention the presence of 'crescents,' and if so, what percentage of my filters are affected?
  3. 3.Did the pathologist find any 'granulomas' in my tissue? (This helps confirm MPA vs. GPA.)
  4. 4.What is my current GFR (Glomerular Filtration Rate), and how will we monitor it to track my kidney health?
  5. 5.Are there any signs of 'fibrinoid necrosis' in my small blood vessels?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Kidney biopsy in patients with antineutrophil cytoplasmic antibody-associated vasculitis with mild renal abnormality.

    Akao S, Yamagiwa G, Hazue R, et al.

    CEN case reports 2023; (12(1)):50-55 doi:10.1007/s13730-022-00719-w.

    PMID: 35817952
  2. 2

    Overlap or Outlier? Granulomatosis With Polyangiitis With Eosinophilia: A Case Report and Diagnostic Insight.

    Zeleke ST, Zaidi SR, Gebremedhen AI, Becker M

    Journal of investigative medicine high impact case reports 2025; (13()):23247096251363027 doi:10.1177/23247096251363027.

    PMID: 40736995
  3. 3

    [ANCA diagnostics in vasculitis].

    Csernok E, Hellmich B

    Zeitschrift fur Rheumatologie 2020; (79(7)):669-678 doi:10.1007/s00393-020-00805-3.

    PMID: 32488364
  4. 4

    Microscopic Polyangiitis: New Insights into Pathogenesis, Clinical Features and Therapy.

    Karras A

    Seminars in respiratory and critical care medicine 2018; (39(4)):459-464 doi:10.1055/s-0038-1673387.

    PMID: 30404112
  5. 5

    Investigations in systemic vasculitis. The role of the laboratory.

    Csernok E, Bossuyt X

    Best practice & research. Clinical rheumatology 2018; (32(1)):52-62 doi:10.1016/j.berh.2018.07.005.

    PMID: 30526898
  6. 6

    The impact of reclassification by the 2022 ACR/EULAR classification criteria on risk factors for relapse in patients with ANCA-associated vasculitis.

    van Leeuwen JR, Hafemann S, van der Boog P, et al.

    Clinical kidney journal 2023; (16(12)):2754-2756 doi:10.1093/ckj/sfad225.

    PMID: 38045999
  7. 7

    Clinical utility of proteinase 3-antineutrophil cytoplasmic antibody at diagnosis in predicting subsequent relapse in patients with microscopic polyangiitis.

    Ha JW, Kwon OC, Park YB, Lee SW

    Frontiers in medicine 2025; (12()):1745280 doi:10.3389/fmed.2025.1745280.

    PMID: 41601767
  8. 8

    Factors associated with pauci-immune glomerulonephritis in patients undergoing kidney biopsy with positive anti-neutrophil cytoplasmic antibody results.

    Lee YJ, Lee J, Ahn SM, et al.

    Journal of nephrology 2025; (38(9)):2919-2928 doi:10.1007/s40620-025-02430-2.

    PMID: 41091444
  9. 9

    Clinical and pathological features of anti-neutrophil cytoplasmic antibody-associated vasculitis in patients with minor urinary abnormalities.

    Hasegawa J, Hoshino J, Sekine A, et al.

    Nephrology (Carlton, Vic.) 2018; (23(11)):1007-1012 doi:10.1111/nep.13157.

    PMID: 28834647
  10. 10

    The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA).

    Weiner M, Segelmark M

    Autoimmunity reviews 2016; (15(10)):978-82.

    PMID: 27481040
  11. 11

    ANCA-Negative Pauci-Immune Glomerulonephritis Associated with Bartonella Endocarditis.

    Ng C, Penney A, Sharaflari R, et al.

    Case reports in nephrology 2024; (2024()):4181660 doi:10.1155/2024/4181660.

    PMID: 39279916
  12. 12

    Renal involvement in eosinophilic granulomatosis with polyangiitis (EGPA): a multicentric retrospective study of 63 biopsy-proven cases.

    Durel CA, Sinico RA, Teixeira V, et al.

    Rheumatology (Oxford, England) 2021; (60(1)):359-365 doi:10.1093/rheumatology/keaa416.

    PMID: 32856066
  13. 13

    2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Microscopic Polyangiitis.

    Suppiah R, Robson JC, Grayson PC, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2022; (74(3)):400-406 doi:10.1002/art.41983.

    PMID: 35106973
  14. 14

    Effective Performance of the 2022 American College of Rheumatology/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Pediatric Patients: An ARChiVe Study.

    Cabral DA, Bosman ES, McPhate N, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2026; doi:10.1002/art.70172.

    PMID: 41958151
  15. 15

    From fibrosis to diagnosis: a paediatric case of microscopic polyangiitis and review of the literature.

    Roszkiewicz J, Smolewska E

    Rheumatology international 2018; (38(4)):683-687 doi:10.1007/s00296-017-3923-y.

    PMID: 29294176
  16. 16

    Microscopic Polyangiitis with Alveolar Hemorrhage Complicated by Myasthenia Gravis.

    Suzuki E, Sumichika Y, Imaizumi M, Kanno T

    Internal medicine (Tokyo, Japan) 2026; (65(11)):1560-1565 doi:10.2169/internalmedicine.5925-25.

    PMID: 41093554

This page explains Microscopic Polyangiitis (MPA) lab and biopsy terminology for educational purposes. Always consult your rheumatologist or nephrologist for help interpreting your specific test results.

Get notified when new evidence is published on Microscopic polyangiitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.